RT Journal Article
SR Electronic
T1 Metastatic Renal Cell Carcinoma with Metabolic Syndrome- A Case Report
JF American Society for Clinical Laboratory Science
JO Clin Lab Sci
FD American Society of Chemistry and Laboratory Science
SP 141
OP 145
DO 10.29074/ascls.23.3.141
VO 23
IS 3
A1 Kelly, Kemper
A1 Cocklin, Carrie
YR 2010
UL http://hwmaint.clsjournal.ascls.org/content/23/3/141.abstract
AB Renal cell carcinoma (RCC) affects patients by proliferating in the renal tubules, resulting in renal failure and concomitant urinalysis findings of blood, protein, casts, and abnormal cells in the urine. If untreated, it can spread to the lymph nodes, liver, and lungs. There is currently no proven tumor marker for RCC. The clinical case reported here describes the clinical laboratory findings in a patient with 2 common co-morbidities (metabolic syndrome and alcoholism), who was found to have metastatic renal cell carcinoma at autopsy. Understanding the clinical chemistry of metastatic carcinoma in the presence of common co-morbidities is important for earlier diagnosis and treatment of patients who are most likely to develop these conditions.ABBREVIATIONS: ALP= Alkaline phosphatase, Hct= Hematocrit, AST= Aspartate aminotransferase, MCV= Mean corpuscular volume, ALT= Alanine transaminase, MCHC= Mean corpuscular hemoglobin concentration, BUN= Blood urea nitrogen, RDW= Red blood cell distribution width, GFR= Glomerular filtration rate, PLT= Platelet, WBC= White Blood Cells, INR= International normalized ratio, aPTT= activated Partial thromboplastin time, GGT= Gamma-glutamyl transferase.